Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

A. L. Godfrey, P. J. Campbell, Cathy MacLean, G. Buck, J. Cook, J. Temple, B. S. Wilkins, Keith Wheatley, J. Nangalia, J. Grinfeld, M. F. McMullin, C. Forsyth, J. J. Kiladjian, A. R. Green, C. N. Harrison

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)
231 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features'. Together they form a unique fingerprint.

Medicine & Life Sciences